Comments on: 药明生物CEO陈智胜博士：复杂分子时代，创新药企更需要专业化与一体化能力兼备的CDMO //haomenintl.net/how-is-the-increasing-complexity-of-modalities-reshaping-cdmo-differentiation-and-specialization-strategies/ 提供端到端一站式解决方案 Mon, 08 Jun 2026 07:06:48 +0000 hourly 1